US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
GB8609537D0
(en)
*
|
1986-04-18 |
1986-05-21 |
Ici Plc |
Polyesters
|
DE3720806C2
(de)
*
|
1986-07-03 |
1997-08-21 |
Clariant Finance Bvi Ltd |
Verwendung eines Stabilisators in Peroxydbleichverfahren
|
US4758435A
(en)
*
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
DE3641692A1
(de)
*
|
1986-12-06 |
1988-06-09 |
Boehringer Ingelheim Kg |
Katalysatorfreie resorbierbare homopolymere und copolymere
|
DE3710175A1
(de)
*
|
1987-02-12 |
1988-08-25 |
Hoechst Ag |
Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
|
US5180765A
(en)
*
|
1988-08-08 |
1993-01-19 |
Biopak Technology, Ltd. |
Biodegradable packaging thermoplastics from lactides
|
US5424346A
(en)
*
|
1988-08-08 |
1995-06-13 |
Ecopol, Llc |
Biodegradable replacement of crystal polystyrene
|
US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
WO1990001521A1
(en)
*
|
1988-08-08 |
1990-02-22 |
Battelle Memorial Institute |
Degradable thermoplastic from lactides
|
AU634723B2
(en)
*
|
1988-08-08 |
1993-03-04 |
Biopak Technology, Ltd. |
Degradable thermoplastic from lactides
|
US5250584A
(en)
*
|
1988-08-31 |
1993-10-05 |
G-C Dental Industrial Corp. |
Periodontium-regenerative materials
|
JP2714454B2
(ja)
*
|
1988-11-07 |
1998-02-16 |
三井東圧化学株式会社 |
生体吸収性ポリエステルの製造方法
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
US5126147A
(en)
*
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
DE4005415C2
(de)
*
|
1990-02-21 |
1996-04-11 |
Boehringer Ingelheim Kg |
Verfahren zum Herstellen von Polyestern auf der Basis von Hydroxycarbonsäuren
|
US5733566A
(en)
*
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5288496A
(en)
*
|
1990-05-15 |
1994-02-22 |
Stolle Research & Development Corporation |
Growth promoters for animals
|
US6353030B1
(en)
*
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
MY108621A
(en)
*
|
1990-08-01 |
1996-10-31 |
Novartis Ag |
Polylactide preparation and purification
|
NZ240214A
(en)
*
|
1990-10-16 |
1993-02-25 |
Takeda Chemical Industries Ltd |
Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
|
IT1249045B
(it)
*
|
1991-02-21 |
1995-02-11 |
Himont Inc |
Processo per la sintesi allo stato solido di polimeri dell'acido lattico e prodotti cosi ottenuti
|
US5142023A
(en)
*
|
1992-01-24 |
1992-08-25 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6005067A
(en)
*
|
1992-01-24 |
1999-12-21 |
Cargill Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6326458B1
(en)
|
1992-01-24 |
2001-12-04 |
Cargill, Inc. |
Continuous process for the manufacture of lactide and lactide polymers
|
US5247059A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for the manufacture of a purified lactide from esters of lactic acid
|
US5247058A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5258488A
(en)
*
|
1992-01-24 |
1993-11-02 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5294469A
(en)
*
|
1992-06-17 |
1994-03-15 |
Mitsui Toatsu Chemicals, Incorporated |
Industrial woven fabric and composite sheet comprising same
|
US5758053A
(en)
*
|
1992-07-22 |
1998-05-26 |
Hitachi, Ltd. |
Fault handling and recovery for system having plural processors
|
DK0615555T3
(da)
*
|
1992-10-02 |
2001-07-09 |
Cargill Inc |
Tekstilmateriale af smeltestabil lactidpolymer og fremgangsmåde til fremstilling deraf
|
DE69322155T2
(de)
*
|
1992-10-02 |
1999-08-19 |
Cargill Inc |
Papier mit einer beschichtung aus schmelzstabilem polymer und dessen verfahren zur herstellung
|
US6005068A
(en)
|
1992-10-02 |
1999-12-21 |
Cargill Incorporated |
Melt-stable amorphous lactide polymer film and process for manufacture thereof
|
US5338822A
(en)
*
|
1992-10-02 |
1994-08-16 |
Cargill, Incorporated |
Melt-stable lactide polymer composition and process for manufacture thereof
|
US5643595A
(en)
*
|
1992-11-24 |
1997-07-01 |
Alkermes Controlled Therapeutics Inc. Ii |
Growth promoters for animals
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
CN1074923C
(zh)
*
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
AU6710196A
(en)
*
|
1995-08-29 |
1997-03-19 |
Kyowa Hakko Kogyo Co. Ltd. |
Process for producing polyhydroxy carboxylic acid
|
SE505146C2
(sv)
*
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
EP0823448A4
(de)
*
|
1996-02-23 |
1998-08-12 |
Kyowa Hakko Kogyo Kk |
Verfahren zur herstellung von polyhydroxycarbonsäure
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6113947A
(en)
*
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6733767B2
(en)
*
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
US6217844B1
(en)
*
|
1998-04-27 |
2001-04-17 |
Praecis Pharmaceuticals, Inc. |
Methods for detecting lesions in dense breast tissue using LHRH antagonists
|
JP2003516443A
(ja)
*
|
1999-12-10 |
2003-05-13 |
ダウ グローバル テクノロジーズ インコーポレイティド |
重縮合反応のための触媒系
|
US6960626B2
(en)
*
|
2000-01-21 |
2005-11-01 |
Cyclics Corporation |
Intimate physical mixtures containing macrocyclic polyester oligomer and filler
|
JP5046447B2
(ja)
*
|
2000-08-07 |
2012-10-10 |
和光純薬工業株式会社 |
乳酸重合体及びその製造方法
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
ES2311542T3
(es)
*
|
2000-08-16 |
2009-02-16 |
Tyco Healthcare Group Lp |
Resina polimerica absorbible de gran consistencia.
|
US7750109B2
(en)
|
2000-09-01 |
2010-07-06 |
Cyclics Corporation |
Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
|
US7767781B2
(en)
|
2000-09-01 |
2010-08-03 |
Cyclics Corporation |
Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
|
CA2451187C
(en)
*
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
CN1547577A
(zh)
|
2001-06-27 |
2004-11-17 |
|
大环低聚酯的分离、配制及成型加工
|
TWI225416B
(en)
*
|
2001-06-29 |
2004-12-21 |
Takeda Chemical Industries Ltd |
Sustained-release composition and process for producing the same
|
AR034641A1
(es)
|
2001-06-29 |
2004-03-03 |
Takeda Pharmaceutical |
Composicion de liberacion controlada y metodo para producirla
|
JP2003192773A
(ja)
*
|
2001-12-26 |
2003-07-09 |
Mitsui Chemicals Inc |
生体吸収性ポリヒドロキシカルボン酸及びその製造法
|
US6849600B2
(en)
*
|
2002-03-25 |
2005-02-01 |
The Regents Of The University Of California, Berkeley |
Corticotropin-releasing hormone analogs
|
KR100684682B1
(ko)
*
|
2002-09-24 |
2007-02-22 |
아사히 가세이 케미칼즈 가부시키가이샤 |
글리콜산 공중합체 및 그의 제조 방법
|
EP1440992A1
(de)
*
|
2003-01-21 |
2004-07-28 |
Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) |
Katalysatorzusammensetzung für die (Co)polymerisation von Lactid und Glycolid
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
CA2819769C
(en)
|
2003-07-18 |
2016-06-28 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
DE112005000965T5
(de)
*
|
2004-04-28 |
2007-03-22 |
Keio University |
Depolymerisationsverfahren für Polymere mit Esterbindung in der Hauptkette und Verfahren zur Herstellung von Polymeren mit Esterbindung in der Hauptkette aus dem Depolymerisationsprodukt
|
JP4723584B2
(ja)
*
|
2004-05-21 |
2011-07-13 |
マイクロ セラピューティクス, インコーポレイテッド |
生物学的、生物分解性若しくは合成重合体又は繊維が巻き付けられた体腔を閉塞するための金属製コイル
|
US20070254314A1
(en)
*
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
EP1793743B1
(de)
|
2004-09-22 |
2009-11-18 |
Dendron GmbH |
Vorrichtung zur implantation von mikrowendeln
|
ATE382337T1
(de)
*
|
2005-04-28 |
2008-01-15 |
Nipro Corp |
Bioabsorbierbare pharmazeutische zusammensetzung enthaltend einen plga-copolymer
|
DE102005019782A1
(de)
*
|
2005-04-28 |
2006-11-09 |
Dendron Gmbh |
Vorrichtung zur Implantation von Okklusionswendeln mit innenliegendem Sicherungsmittel
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
JP2009520693A
(ja)
*
|
2005-12-08 |
2009-05-28 |
エムディーアールエヌエー,インコーポレイテッド |
安定化されたエキセンディン製剤の粘膜送達
|
CA2858359C
(en)
|
2006-11-01 |
2018-04-03 |
Ventana Medical Systems, Inc. |
Haptens, hapten conjugates, compositions thereof and method for their preparation and use
|
GEP20125597B
(en)
*
|
2006-12-18 |
2012-08-10 |
Takeda Pharmaceutical |
Sustained-release composition and production method thereof
|
JP5249249B2
(ja)
|
2007-03-13 |
2013-07-31 |
コヴィディエン リミテッド パートナーシップ |
コイルと耐伸張性部材とが含まれているインプラント
|
AU2009270695A1
(en)
|
2008-07-17 |
2010-01-21 |
Ap Pharma |
Methods for enhancing the stability of polyorthoesters and their formulations
|
CA2741030A1
(en)
|
2008-10-20 |
2010-04-29 |
Marvin C. Gershengorn |
Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
|
CA2740970A1
(en)
|
2008-10-21 |
2010-04-29 |
Oregon Health & Science University |
Naphthamides as anticancer agents
|
CN101445595B
(zh)
*
|
2008-12-26 |
2011-01-19 |
上海新上化高分子材料有限公司 |
聚乙丙交酯及其制备方法和应用
|
US9365612B2
(en)
|
2010-01-29 |
2016-06-14 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Caspase inhibitors
|
CA2789818A1
(en)
|
2010-04-08 |
2011-10-13 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Inverse agonists and neutral antagonists for the tsh receptor
|
WO2012125486A1
(en)
|
2011-03-11 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination chemotherapy for treating cancer
|
EP2685985B1
(de)
|
2011-03-17 |
2016-08-31 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Verfahren zur behandlung von leukämie und erkrankungen durch cbf- und runx1-proteine
|
CN102329269B
(zh)
*
|
2011-06-30 |
2013-07-17 |
南京大学 |
仿生氯化肌酐胍催化缩聚法合成高分子量聚乳酸
|
CN102295765B
(zh)
*
|
2011-06-30 |
2012-11-28 |
南京大学 |
生物质肌酐催化共缩聚法合成聚乳酸-乙醇酸
|
US20140348865A1
(en)
|
2011-09-12 |
2014-11-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Ser. |
Immunogens based on an hiv-1 v1v2 site-of-vulnerability
|
US20140234360A1
(en)
|
2011-09-30 |
2014-08-21 |
The United States of America, as represented by the Secretary, Dept.of Health and Human Services |
Influenza vaccine
|
WO2013106847A1
(en)
|
2012-01-13 |
2013-07-18 |
Oregon Health & Science University |
Compounds, compositions and associated methods comprising 3-aryl quinolines
|
AU2013272288B2
(en)
|
2012-06-08 |
2018-01-18 |
The United States Government As Represented By The Department Of Veterans Affairs |
FBXO3 inhibitors
|
JP6272626B2
(ja)
|
2012-11-13 |
2018-01-31 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
カンナビノイド受容体媒介性化合物
|
US9775895B2
(en)
|
2012-12-12 |
2017-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HIV therapeutics and methods of making and using same
|
CN105611927A
(zh)
|
2013-05-16 |
2016-05-25 |
美国政府(由卫生和人类服务部的部长所代表) |
用于抑制耐药性hiv-1整合酶耐药株的化合物
|
JP6564380B2
(ja)
|
2013-09-20 |
2019-08-21 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
前立腺癌を治療するための化合物
|
US10398772B2
(en)
|
2014-01-08 |
2019-09-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Ras pathways as markers of protection against HIV and methods to improve vaccine efficacy
|
EP3140288B1
(de)
|
2014-05-09 |
2023-01-25 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Pyrazol-derivate und deren verwendung als mediatoren des cannabinoid-rezeptors
|
DK3185868T3
(da)
|
2014-08-25 |
2022-05-23 |
Salk Inst For Biological Studi |
Hidtil ukendte ULK1-inhibitorer og fremgangsmåder til anvendelse af samme
|
WO2016037154A1
(en)
|
2014-09-04 |
2016-03-10 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Recombinant hiv-1 envelope proteins and their use
|
WO2016064716A1
(en)
|
2014-10-20 |
2016-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination therapy of tshr antagonist and igfr inhibitor
|
EP3236998A1
(de)
|
2014-12-24 |
2017-11-01 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Rekombinante metapneumovirusproteine und deren verwendung
|
EP3242661B1
(de)
|
2015-01-05 |
2019-08-21 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Myc-g-quadruplex-stabilisierende kleine moleküle und deren verwendung
|
JP2018510849A
(ja)
|
2015-02-20 |
2018-04-19 |
オレゴン・ヘルス・アンド・サイエンス・ユニバーシティ |
ソベチロムの誘導体
|
EP3303325A1
(de)
|
2015-06-04 |
2018-04-11 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Cannabinoid-rezeptorvermittelnde verbindungen
|
WO2017044803A1
(en)
|
2015-09-09 |
2017-03-16 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Service |
Expression vector delivery system and use thereof for inducing an immune response
|
CN108699043A
(zh)
|
2016-03-04 |
2018-10-23 |
美国政府(由卫生和人类服务部的部长所代表) |
大麻素受体介导化合物
|
HUE056357T2
(hu)
|
2016-05-18 |
2022-02-28 |
Univ Oregon Health & Science |
Szobetirom származékok
|
US20190255079A1
(en)
|
2016-06-16 |
2019-08-22 |
Acies Bio D.O.O. |
Compositions and methods useful for treating diseases characterized by insufficient pantothenate kinase activity
|
MX2019006349A
(es)
|
2016-12-16 |
2019-08-22 |
Inst Res Biomedicine |
Proteinas recombinantes rsv f de prefusion nuevas y usos de las mismas.
|
EP3675921A1
(de)
|
2017-08-31 |
2020-07-08 |
Evonik Corporation |
Verbessertes reinigungsverfahren für resorbierbare polymere
|
WO2019118803A1
(en)
|
2017-12-14 |
2019-06-20 |
The United States Of America, As Represented By The Secretary,Department Of Health And Human Services |
Chemical entities for lytic activation of kshv and therapeutic targeting of viral enzymes/proteins
|
MX2020009391A
(es)
|
2018-03-29 |
2021-01-08 |
Elex Biotech Inc |
Compuestos para el tratamiento de arritmias cardiacas e insuficiencia cardiaca.
|
CA3110224A1
(en)
|
2018-09-25 |
2020-04-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
|
CN113423684A
(zh)
|
2018-12-12 |
2021-09-21 |
速通医疗公司 |
新型拟甲状腺素药
|
US11667606B2
(en)
|
2019-03-01 |
2023-06-06 |
Autobahn Therapeutics, Inc. |
Thyromimetics
|
EP3937917B1
(de)
|
2019-03-11 |
2023-11-15 |
Oregon State University |
Analoga und derivate von cephalotaxin und verfahren zur herstellung und verwendung der verbindungen
|
CA3222837A1
(en)
|
2021-06-09 |
2022-12-15 |
John S. Schneekloth |
Compounds that bind non-canonical g-quadruplex structures and methods of making and using the same
|
WO2023059867A1
(en)
|
2021-10-08 |
2023-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for treating or preventing alzheimer's disease
|
WO2023146771A1
(en)
|
2022-01-25 |
2023-08-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gingerenone a prodrugs as senotherapeutics and methods of use
|
WO2023177568A1
(en)
|
2022-03-14 |
2023-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor modulating compounds
|